Selected article for: "complex type and hybrid type complex"

Author: Yasunori Watanabe; Joel D. Allen; Daniel Wrapp; Jason S. McLellan; Max Crispin
Title: Site-specific analysis of the SARS-CoV-2 glycan shield
  • Document date: 2020_3_28
  • ID: 63j4qc7d_9
    Snippet: There are three sites on SARS-CoV-2 that are predominantly oligomannose-type: N234, N709 and N801. The predominant structure observed at each site, with the exception of N234, is Man5GlcNAc2, which demonstrates that these sites are largely accessible to a 1,2mannosidases but are poor substrates for GlcNAcT-I, which is the gateway enzyme in the formation of hybrid-and complex-type glycans in the Golgi apparatus. The stage at which processing is.....
    Document: There are three sites on SARS-CoV-2 that are predominantly oligomannose-type: N234, N709 and N801. The predominant structure observed at each site, with the exception of N234, is Man5GlcNAc2, which demonstrates that these sites are largely accessible to a 1,2mannosidases but are poor substrates for GlcNAcT-I, which is the gateway enzyme in the formation of hybrid-and complex-type glycans in the Golgi apparatus. The stage at which processing is impeded is a signature related to the density and presentation of glycans on the viral spike. For example, the more densely glycosylated spikes of HIV-1 Env and Lassa virus GPC give rise to numerous sites dominated by Man9GlcNAc2 [20] [21] [22] 26 .

    Search related documents:
    Co phrase search for related documents
    • complex type and Golgi apparatus: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • complex type and Lassa virus: 1
    • complex type and oligomannose type: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • complex type and predominant structure: 1
    • complex type and SARS site: 1, 2, 3
    • complex type hybrid and densely glycosylated spike: 1
    • complex type hybrid and Golgi apparatus: 1, 2
    • complex type hybrid and oligomannose type: 1, 2, 3, 4, 5, 6, 7
    • complex type hybrid glycan and densely glycosylated spike: 1
    • complex type hybrid glycan and oligomannose type: 1, 2, 3, 4
    • densely glycosylated spike and oligomannose type: 1
    • densely glycosylated spike and SARS site: 1
    • Lassa virus and oligomannose type: 1, 2
    • oligomannose type and SARS site: 1, 2